STOCK TITAN
  1. Home
  2. Sec-filings
  3. VCEL
  4. [Form 4] Vericel Corp Insider Trading Activity

Vericel (VCEL) director receives new RSU and stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vericel Corp director Kevin F. McLaughlin reported compensation-related equity activity. He exercised 3,200 previously granted Restricted Stock Units (RSUs) into 3,200 shares of common stock, bringing his direct common stock holdings to 18,300 shares after the transactions.

On the same date, he received new awards of 3,200 RSUs and stock options for 8,000 shares of common stock at an exercise price of $33.43 per share. The new RSUs vest 100% on the earlier of April 29, 2027, or the first Annual Meeting of Stockholders following April 29, 2026, while the options vest over one year in equal monthly increments, contingent on continued service.

Positive

  • None.

Negative

  • None.
Insider MCLAUGHLIN KEVIN F
Role null
Type Security Shares Price Value
Exercise Restricted Stock Unit 3,200 $0.00 --
Grant/Award Stock Option (Right to Buy) 8,000 $0.00 --
Grant/Award Restricted Stock Unit 3,200 $0.00 --
Exercise Common Stock 3,200 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct, null); Stock Option (Right to Buy) — 8,000 shares (Direct, null); Common Stock — 18,300 shares (Direct, null)
Footnotes (1)
  1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025. No expiration date for this type of award. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
RSUs exercised into common stock 3,200 shares Converted to common stock on April 29, 2026
Common stock held after transactions 18,300 shares Direct ownership after April 29, 2026 activity
New RSU grant 3,200 RSUs Awarded April 29, 2026, vests by April 29, 2027 trigger
New stock option grant 8,000 options Right to buy common stock awarded April 29, 2026
Stock option exercise price $33.43 per share Conversion or exercise price for 8,000 options
Stock option expiration April 29, 2036 Expiration date of 8,000-share option grant
Restricted Stock Unit financial
"The shares of common stock were acquired ... as a result of the vesting of Restricted Stock Units (RSUs)"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each RSU represents a contingent right to receive one share of common stock"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title "Common Stock""
Annual Meeting of Stockholders financial
"These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders"
contingent right financial
"Each RSU represents a contingent right to receive one share of common stock"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCLAUGHLIN KEVIN F
(Last)(First)(Middle)
C/O VERICEL CORPORATION
64 SIDNEY STREET
(Street)
CAMBRIDGE MASSACHUSETTS 02139
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Vericel Corp [ VCEL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/29/2026M3,200A(1)18,300D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(2)04/29/2026M3,200 (3) (4)Common Stock3,200$00D
Stock Option (Right to Buy)$33.4304/29/2026A8,000 (5)04/29/2036Common Stock8,000$08,000D
Restricted Stock Unit(2)04/29/2026A3,200 (6) (4)Common Stock3,200$03,200D
Explanation of Responses:
1. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025.
2. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
3. These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
4. No expiration date for this type of award.
5. The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
6. These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin05/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Vericel (VCEL) director Kevin McLaughlin report?

Kevin McLaughlin reported equity compensation activity, not open-market trades. He exercised 3,200 RSUs into common stock and received new grants of 3,200 RSUs plus options for 8,000 shares, all dated April 29, 2026.

Did the Vericel (VCEL) director buy or sell shares in the market?

The filing shows no open-market purchases or sales. All Form 4 entries reflect equity compensation: RSUs vesting into shares and new grants of RSUs and stock options, rather than discretionary market trades.

How many Vericel (VCEL) shares does Kevin McLaughlin hold after these transactions?

After these transactions, McLaughlin directly holds 18,300 shares of common stock. In addition, he holds 3,200 RSUs representing future rights to shares and stock options for 8,000 shares at a $33.43 exercise price.

What are the key terms of Kevin McLaughlin’s new Vericel (VCEL) stock options?

The new stock options cover 8,000 shares at a $33.43 exercise price. They vest over one year in equal monthly increments, contingent on his continued service, and expire on April 29, 2036, if not exercised earlier.

When do Kevin McLaughlin’s new Vericel (VCEL) RSUs vest?

The newly granted 3,200 RSUs vest 100% on a single future date. They vest on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026, assuming continued service.